25-Hydroxyvitamin D levels and Lupus Outcomes
25-Hydroxyvitamin D levels and Lupus Outcomes jjcush@gmail.com Mon, 11/17/2025 – 18:37
RheumNow
RheumNow
RheumNow
Can EMR Treatment Suggestions Improve Decision Making? In a new study, researchers from Northwestern University and th
Can EMR Treatment Suggestions Improve Decision Making? In a new study, researchers from Northwestern University and th https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,
RheumNow
Hospital Mortality in Dermatomyositis A cohort study reveals that hospitalized patients with dermatomyositis have a hi
Hospital Mortality in Dermatomyositis A cohort study reveals that hospitalized patients with dermatomyositis have a hi https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 11/17/2025
RheumNow
+ANA’s are common in pregnancy. Study of 2159 Chinese 1st trimester pregnant women found ANAs positivity in 14.7 % (1:10
+ANA’s are common in pregnancy. Study of 2159 Chinese 1st trimester pregnant women found ANAs positivity in 14.7 % (1:10
RheumNow
“The good physician treats the disease; the great physician treats the patient who has the disease.” – Elizabeth Black
“The good physician treats the disease; the great physician treats the patient who has the disease.” – Elizabeth Black https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
A JAKi in GCA: 2-year efficacy and safety results in a Phase 3 study Discover how continued treatment with a JAKi impa
A JAKi in GCA: 2-year efficacy and safety results in a Phase 3 study Discover how continued treatment with a
RheumNow
Beyond malignancy, look out for LICATS with CAR-T CD19 chimeric antigen receptor (CAR) T cell therapy took the centre
Beyond malignancy, look out for LICATS with CAR-T CD19 chimeric antigen receptor (CAR) T cell therapy took the centre https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
GLP-1 Receptor Agonists in PsA: Mortality and MACE Dr. Antoni Chan reports on abstract 0849 (Mortality and Major Advers
GLP-1 Receptor Agonists in PsA: Mortality and MACE Dr. Antoni Chan reports on abstract 0849 (Mortality and Major Advers https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Tocilizumab Beats Methotrexate in GCA Dr. Mike Putman reports on abstract 0891 (MEthotrexate versus TOcilizumab for tr
Tocilizumab Beats Methotrexate in GCA Dr. Mike Putman reports on abstract 0891 (MEthotrexate versus TOcilizumab for tr https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,
RNL 25 Replay: Rheumatoid Arthritis
RNL 25 Replay: Rheumatoid Arthritis tammytilley@gm… Fri, 11/14/2025 – 14:12 Education/ACR/EULAR Rheumatoid Arthritis Enjoy these excerpts from the RNL 2025
RheumNow
Taking a closer look: B-Cell depletion beyond the blood At #ACR25, we have seen an exciting wave of cellular and immun
Taking a closer look: B-Cell depletion beyond the blood At #ACR25, we have seen an exciting wave of cellular and
RheumNow
ACR 2025 CAR-T Topic Panel A focused conversation on the latest in CAR-T from emerging data and treatment strategies t
ACR 2025 CAR-T Topic Panel A focused conversation on the latest in CAR-T from emerging data and treatment strategies t
RheumNow
ACR 2025 SpA Topic Panel A focused discussion on updates in spondyloarthritis, including emerging data, treatment stra
ACR 2025 SpA Topic Panel A focused discussion on updates in spondyloarthritis, including emerging data, treatment stra https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri,
RheumNow
Having #RA does not increase mortality in CA pts Rx w/ immune checkpoint inhibitors (ICI). 301 Veterans w/ RA & 2114
Having #RA does not increase mortality in CA pts Rx w/ immune checkpoint inhibitors (ICI). 301 Veterans w/ RA &
ICYMI: Head-to-Head Clinical Trials
ICYMI: Head-to-Head Clinical Trials tammytilley@gm… Fri, 11/14/2025 – 06:00 Image By downloading this material, I acknowledge that it may be
RheumNow
SLE Prospect. Observational Study of 826 SLE pts over 3 yr for outcomes& IFN signature (IFNGS). 71% were IFNGS-high.
SLE Prospect. Observational Study of 826 SLE pts over 3 yr for outcomes& IFN signature (IFNGS). 71% were IFNGS-high. https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
IL-1 Inhibition in CPPD Controlled clinical trials in patients with calcium Pyrophosphate Deposition Disease (CPPD) ar
IL-1 Inhibition in CPPD Controlled clinical trials in patients with calcium Pyrophosphate Deposition Disease (CPPD) ar https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 11/13/2025
RheumNow
Can EMR Treatment Suggestions Improve Decision Making?
Can EMR Treatment Suggestions Improve Decision Making? jjcush@gmail.com Thu, 11/13/2025 – 15:54
RheumNow
DAHLIAS study – Nipocalimab in Sjögren’s Disease Nipocalimab, a neonatal Fc receptor blocker that reduces circulating
DAHLIAS study – Nipocalimab in Sjögren’s Disease Nipocalimab, a neonatal Fc receptor blocker that reduces circulating https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu, 11/13/2025
RheumNow
Robinson et al has published that Epstein-Barr virus infects and reprograms autoreactive B cells to drive the systemic a
Robinson et al has published that Epstein-Barr virus infects and reprograms autoreactive B cells to drive the systemic a https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
Hospital Mortality in Dermatomyositis
Hospital Mortality in Dermatomyositis jjcush@gmail.com Thu, 11/13/2025 – 15:35
RheumNow
Mesothelin as a biomarker and potential therapeutic target in rheumatoid arthritis? Mesothelin is elevated in RA & a
Mesothelin as a biomarker and potential therapeutic target in rheumatoid arthritis? Mesothelin is elevated in RA & a https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
Day 2 Recap: #ACR25 Highlights Join RheumNow Faculty Drs. David Liew, Antoni Chan, Mrinalini Dey, and Jack Cush as the
Day 2 Recap: #ACR25 Highlights Join RheumNow Faculty Drs. David Liew, Antoni Chan, Mrinalini Dey, and Jack Cush as the
RheumNow
Putting Steroid Tapering into Practice in SLE Drs. Yuz Yusof and Ed Vital discuss abstract 1526 (Guidance For Corticos
Putting Steroid Tapering into Practice in SLE Drs. Yuz Yusof and Ed Vital discuss abstract 1526 (Guidance For Corticos https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RheumNow
CAR-T Therapy: Where is it Heading? Dr. Peter Nash summarizes several abstracts looking at CAR-T therapy from #ACR25.
CAR-T Therapy: Where is it Heading? Dr. Peter Nash summarizes several abstracts looking at CAR-T therapy from #ACR25. https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
Deep Learning Model Accurately Detects Ankylosing Spondylitis on MRI AI continues to move from research labs into rheu
Deep Learning Model Accurately Detects Ankylosing Spondylitis on MRI AI continues to move from research labs into rheu https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RheumNow
Western Australia study of 1854 SLE pts (median 40 yrs old). Interstitial lung disease was seen in in 3.8% of SLE, 26 fo
Western Australia study of 1854 SLE pts (median 40 yrs old). Interstitial lung disease was seen in in 3.8% of